Table 2 Univariate and multivariate analyses associated with the overall survival (n = 411).

From: Prognostic significance of bone marrow and spleen 18F-FDG uptake in patients with colorectal cancer

 

Univariate analysis

Multivariate analysis

HR (95% CI)

p

HR (95% CI)

p

Sex

Female

Ref

   

Male

1.12 (0.772–1.625)

0.55

  

Age (years)

< 70

Ref

 

Ref

 

≥ 70

2.261 (1.579–3.238)

< 0.001

2.623 (1.772–3.882)

< 0.001

ASA

1

Ref

 

Ref

 

2

1.793 (1.225–2.625)

0.002

1.921 (1.280–2.883)

0.001

3 and 4

1.153 (0.597–2.227)

0.671

0.707 (0.352–1.417)

0.328

No data

1.145 (0.157–8.315)

0.893

0.974 (0.126–7.495)

0.980

BMI (kg/m2)

< 25

Ref

 

Ref

 

≥ 25

0.424 (0.253–0.708)

0.001

0.431 (0.252–0.738)

0.002

Preop-CEA (ng/mL)

< 5

Ref

 

Ref

 

≥ 5

1.793 (1.251–2.57)

0.001

1.339 (0.910–1.972)

0.138

Tumor location

Rt. colon

Ref

   

Lt. colon

0.927 (0.605–1.421)

0.730

  

Rectum

0.916 (0.571–1.471)

0.719

  

Tumor size (cm)

< 5

Ref

   

≥ 5

1.516 (1.058–2.172)

0.023

  

Histologic grade

G1

Ref

   

G2

1.514 (0.788–2.907)

0.213

  

G3

1.711 (0.621–4.713)

0.299

  

Etc

1.485 (0.564–3.905)

0.423

  

LVI

Absent

Ref

 

Ref

 

Present

2.078 (1.429–3.02)

< 0.001

1.602 (1.054–2.435)

0.027

No data

1.621 (0.590–4.45)

0.348

1.485 (0.514–4.286)

0.464

Number of retrieved LNs

< 12

Ref

 

Ref

 

≥ 12

0.628 (0.411–0.960)

0.031

0.407 (0.259–0.639)

< 0.001

Stage

I and II

Ref

 

Ref

 

III

1.501 (0.983–2.291)

0.059

2.056 (1.286–3.287)

0.002

IV

5.437 (3.401–8.692)

< 0.001

5.560 (3.216–9.610)

< 0.001

MSI

MSS/MSI-low

Ref

   

MSI-high

0.643 (0.280–1.479)

0.300

  

No data

0.962 (0.654–1.415)

0.846

  

KRAS

Wild

Ref

   

Mutant

1.075 (0.565–2.041)

0.826

  

No data

1.336 (0.861–2.073)

0.196

  

Chemotherapy

No

Ref

 

Ref

 

Yes

0.523 (0.365–0.750)

< 0.001

0.536 (0.357–0.805)

0.002

NLR

< 3

Ref

   

≥ 3

1.432 (0.997–2.057)

0.051

  

TLR

Continuous

1.002 (0.934–1.073)

0.965

  

BLR

Continuous

4.638 (1.958–10.99)

< 0.001

5.279 (2.337–11.922)

< 0.001

SLR

Continuous

2.686 (1.097–6.574)

0.030

  
  1. HR hazard ratio, CI confidence interval, ASA American Society of Anesthesiology, BMI body mass index, CEA carcinoembryonic antigen, LVI lymphovascular invasion, LN lymph node, MSI microsatellite instability, MSS microsatellite Stable, NLR neutrophil-to-lymphocyte ratio, TLR tumor-to-liver ratio, BLR bone marrow-to-liver ratio, SLR spleen-to-liver ratio.